Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
Pediatric Brain Tumor Consortium Identifier:
First received: September 11, 2000
Last updated: October 6, 2009
Last verified: October 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: May 2003 (Final data collection date for primary outcome measure)